Literature DB >> 25964870

Molecular interactions between hepatitis B virus and delta virus.

Elham Shirvani-Dastgerdi1, Frank Tacke1.   

Abstract

As a deficient virus due to the lack of envelope proteins, hepatitis D virus (HDV) causes chronic or fulminant "delta hepatitis" only in people with simultaneous hepatitis B virus (HBV) infection. HBV encodes three types of surface proteins known as small (S), medium (M) and large (L) envelope proteins. All three types of HBV surface antigens (HBsAgs) are present on HDV virions. The envelopment process of HDV occurs through interactions between the HDV ribonucleoprotein (RNP) complex and HBV HBsAgs. While HBsAg is the only protein required by HDV, the exact interaction sites between the S protein and pre-mature HDV are not well defined yet. In fact, these sites are distributed along the S protein with some hot spots for the envelopment process. Moreover, in most clinically studied samples, HDV infection is associated with a dramatically reduced HBV viral load, temporarily or permanently, while HBsAg resources are available for HDV packaging. Thus, beyond interacting with HBV envelope proteins, controlling mechanisms exist by which HDV inhibits HBV-DNA replication while allowing a selective transcription of HBV proteins. Here we discuss the molecular interaction sites between HBsAg and the HDV-RNP complex and address the proposed indirect mechanisms, which are employed by HBV and HDV to facilitate or inhibit each other's viral replication. Understanding molecular interactions between HBV and HDV may help to design novel therapeutic strategies for delta hepatitis.

Entities:  

Keywords:  Ag loop; Hepatitis B virus; Hepatitis B virus surface antigens; Hepatitis D virus; Hepatitis D virus antigen; Liver cirrhosis; Viral hepatitis

Year:  2015        PMID: 25964870      PMCID: PMC4419120          DOI: 10.5501/wjv.v4.i2.36

Source DB:  PubMed          Journal:  World J Virol        ISSN: 2220-3249


  41 in total

1.  Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.

Authors:  Melanie Schaper; Francisco Rodriguez-Frias; Rosendo Jardi; David Tabernero; Maria Homs; Gerardo Ruiz; Josep Quer; Rafael Esteban; Maria Buti
Journal:  J Hepatol       Date:  2010-03-05       Impact factor: 25.083

2.  A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles.

Authors:  Isabelle Komla-Soukha; Camille Sureau
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.

Authors:  H Sakugawa; H Nakasone; T Nakayoshi; Y Kawakami; T Yamashiro; T Maeshiro; F Kinjo; A Saito; H Zukeran
Journal:  J Med Virol       Date:  2001-11       Impact factor: 2.327

4.  Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.

Authors:  R Jardi; F Rodriguez; M Buti; X Costa; M Cotrina; R Galimany; R Esteban; J Guardia
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

5.  Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.

Authors:  Chi-Ruei Huang; Szecheng John Lo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

6.  Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications.

Authors:  Sheng-Chieh Hsu; Wan-Jr Syu; I-Jane Sheen; Hui-Ting Liu; King-Song Jeng; Jaw-Ching Wu
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  Hepatitis B: the virus and disease.

Authors:  T Jake Liang
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin.

Authors:  Michele Soares Gomes-Gouvêa; Manoel do Carmo Pereira Soares; Isabel Maria Vicente Guedes de Carvalho Mello; Elisabete Maria Figueiredo Brito; Lizomar de Jesus Maués Pereira Moia; Gilberta Bensabath; Heloisa Marceliano Nunes; Flair José Carrilho; João Renato Rebello Pinho
Journal:  Acta Trop       Date:  2008-03-18       Impact factor: 3.112

Review 9.  An update on hepatitis B, D, and E viruses.

Authors:  Jennifer Price
Journal:  Top Antivir Med       Date:  2014-01

10.  Eighth major clade for hepatitis delta virus.

Authors:  Frédéric Le Gal; Elyanne Gault; Marie-Pierre Ripault; Jeanne Serpaggi; Jean-Claude Trinchet; Emmanuel Gordien; Paul Dény
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

View more
  6 in total

1.  Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.

Authors:  Benjamin Y Winer; Elham Shirvani-Dastgerdi; Yaron Bram; Julie Sellau; Benjamin E Low; Heath Johnson; Tiffany Huang; Gabriela Hrebikova; Brigitte Heller; Yael Sharon; Katja Giersch; Sherif Gerges; Kathleen Seneca; Mihai-Alexandru Pais; Angela S Frankel; Luis Chiriboga; John Cullen; Ronald G Nahass; Marc Lutgehetmann; Jared E Toettcher; Michael V Wiles; Robert E Schwartz; Alexander Ploss
Journal:  Sci Transl Med       Date:  2018-06-27       Impact factor: 17.956

2.  Impact of nucleic acid extraction platforms on hepatitis virus genome detection.

Authors:  Matthew D Pauly; Saleem Kamili; Tonya M Hayden
Journal:  J Virol Methods       Date:  2019-08-13       Impact factor: 2.014

Review 3.  Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.

Authors:  Elham Shirvani-Dastgerdi; Robert E Schwartz; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2016-08-06       Impact factor: 7.090

4.  Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.

Authors:  Hung Minh Nguyen; Bui Tien Sy; Nguyen Thanh Trung; Nghiem Xuan Hoan; Heiner Wedemeyer; Thirumalaisamy P Velavan; C-Thomas Bock
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

5.  HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.

Authors:  Luna Colagrossi; Romina Salpini; Rossana Scutari; Luca Carioti; Arianna Battisti; Lorenzo Piermatteo; Ada Bertoli; Lavinia Fabeni; Carmine Minichini; Pascale Trimoulet; Hervé Fleury; Elena Nebuloso; Maria De Cristofaro; Giuseppina Cappiello; Alberto Spanò; Vincenzo Malagnino; Terenzio Mari; Angelo Barlattani; Nerio Iapadre; Miriam Lichtner; Claudio Mastroianni; Ilaria Lenci; Caterina Pasquazzi; Giuseppe Maria De Sanctis; Alfonso Galeota Lanza; Maria Stanzione; Gianfranca Stornaiuolo; Massimo Marignani; Loredana Sarmati; Massimo Andreoni; Mario Angelico; Francesca Ceccherini-Silberstein; Carlo-Federico Perno; Nicola Coppola; Valentina Svicher
Journal:  Viruses       Date:  2018-07-09       Impact factor: 5.048

Review 6.  Hepatitis delta virus and hepatocellular carcinoma: an update.

Authors:  Raffaella Romeo; Arnolfo Petruzziello; Eve Isabel Pecheur; Floriana Facchetti; Riccardo Perbellini; Enrico Galmozzi; Najeeb Ullah Khan; Lucia Di Capua; Rocco Sabatino; Gerardo Botti; Giovanna Loquercio
Journal:  Epidemiol Infect       Date:  2018-07-11       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.